Definitive Contract 75F40123C00094

Award Date 8/9/23
Potential Completion Date 8/29/25
Potential Value $4.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,940,013.28 Definitive Contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for post-market safety studies and has a completion date of March 20, 2022. It is an 8(a) sole source award. ICA is a specialized healthcare IT and management consulting firm that has an extensive track record of supporting federal health agencies like the FDA and...
The Food and Drug Administration (FDA) awarded a $3,821,128.80 firm-fixed-price contract to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. This contract is part of the FDA's Center for Devices and Radiological Health's (CDRH) Medical Data Enterprise Initiative, which aims to streamline the use of real-world data and integrate it with CDRH data. ICA will provide advanced data analytics, artificial intelligence, healthcare...
This is a $3,539,788.80 firm-fixed price definitive contract awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The contract is for the scale-up of an existing Medical Device Evaluation (MDE) Artificial Intelligence (AI) pilot to an operational tool. ICA has an extensive track record supporting federal health agencies like HHS and...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to International Consulting Associates Inc. (ICA), an SBA-certified 8(a) small business. The $202,946.14 contract is for research to evaluate how the FDA's Center for Devices and Radiological Health (CDRH) assesses real-world evidence in regulatory submissions and identify best practices. ICA, a minority-owned small business, specializes in healthcare data...
This $3,976,584.00 firm fixed price federal contract was awarded to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business, by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS). The 2-year contract, titled "CDRH REAL-WORLD DATA ANALYSES," is for ICA to provide advanced data analytics, artificial intelligence, healthcare IT, and management consulting services...
This federal contract award for $3,885,609.18 was issued by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services (HHS), to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for literature analysis services to support the Center for Devices and Radiological Health (CDRH) within the FDA. This is a definitive, firm fixed-price contract with a completion date...
This is a $647,382.17 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The contract is for the identification of real-world evidence (RWE) used in premarket regulatory submissions. ICA has established itself as a key partner for federal health agencies, providing advanced data analytics, artificial intelligence, healthcare IT, and...
The U.S. Food and Drug Administration (FDA) has awarded a $4,077,696.00 Firm Fixed Price, Definitive Contract to International Consulting Associates, Inc. (ICA) to develop AI-enabled user workflows and dashboards for the Center for Devices and Radiological Health (CDRH). This 8(a) sole source contract, running through September 2024, is part of the FDA's broader "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative. ICA, an...
This is a $408,041.60 Firm Fixed Price definitive contract awarded to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business, by the Food and Drug Administration (FDA) to provide CMMS Analytics Tool Enhancements for the Center for Devices and Radiological Health (CDRH). The contract is set-aside for 8(a) businesses and runs through September 28, 2023. ICA is a healthcare IT and management consulting firm that specializes in advanced...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The $99,926.40 contract is for consulting services to support research and evaluation of electronic health records (EHR). ICA has an extensive track record providing data analytics, AI/ML, healthcare IT, and management consulting services to federal health...

This is a $4,456,062.35 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for support to conduct 10 post-market safety studies, with a period of performance through August 29, 2025. ICA has an extensive track record of delivering a wide range of healthcare IT, data analytics, and management consulting services to federal health agencies like the FDA and Centers for Medicare and Medicaid Services (CMS). This contract is part of the FDA's "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative, which aims to modernize medical product evaluation and monitoring capabilities through predictive modeling and post-market safety surveillance tools. The contract is not set-aside, and ICA may partner with large prime contractors like Booz Allen Hamilton to leverage its specialized expertise.

Generated 1/17/25, 9:09 AM